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Abstract. Mammalian polo-like kinase 1 (Plkl) is 
structurally related to the polo gene product of Dro- 
sophila melanogaster, Cdc5p of Saccharomyces cerevi- 
siae, and plol ÷ of Schizosaccharornyces pombe, a newly 
emerging family of serine-threonine kinases implicated 
in cell cycle regulation. Based on data obtained for its 
putative homologues in invertebrates and yeasts, hu- 
man Plkl is suspected to regulate some fundamental as- 
pect(s) of mitosis, but no direct experimental evidence 
in support of this hypothesis has previously been re- 
ported. In this study, we have used a cell duplication, 
microinjection assay to investigate the in vivo function 
of Plkl in both immortalized (HeLa) and nonimmortal- 
ized (Hs68) human cells. Injection of anti-Plkl antibod- 
ies (Plkl +) at various stages of the cell cycle had no ef- 
fect on the kinetics of DNA replication but severely 
impaired the ability of cells to divide. Analysis of 
Plkl +-injected, mitotically arrested HeLa cells by fluo- 
rescence microscopy revealed abnormal distributions 
of condensed chromatin and monoastral microtubule 
arrays that were nucleated from duplicated but unsepa- 
rated centrosomes. Most strikingly, centrosomes in 
Plkl +-injected cells were drastically reduced in size, 
and the accumulation of both ~/-tubulin and MPM-2 im- 
munoreactivity was impaired. These data indicate that 
Plkl activity is necessary for the functional maturation 
of centrosomes in late G2/early prophase and, conse- 
quently, for the establishment of a bipolar spindle. Ad- 
ditional roles for Plkl at later stages of mitosis are not 
excluded, although injection of Plkl + after the comple- 
tion of spindle formation did not interfere with cytoki- 
nesis. Injection of Plkl + into nonimmortalized Hs68 
cells produced qualitatively similar phenotypes, but the 
vast majority of the injected Hs68 cells arrested as sin- 
gle, mononucleated cells in G2. This latter observation 
hints at the existence, in nonimmortalized cells, of a 
centrosome-maturation checkpoint sensitive to the im- 
pairment of Plkl function. 
C 
ELt cycle progression in all eukaryotes depends on 
the periodic activation and inactivation of cyclin- 
dependent kinases (for reviews see Norbury and 
Nurse, 1992; Morgan, 1995; Nigg, 1995). However, it is be- 
coming increasingly clear that protein kinases structurally 
distinct from cyclin-dependent kinases also play important 
roles in the regulation of cell cycle events. One prominent, 
newly emerging family of serine/threonine-kinases with a 
likely role in cell cycle control is represented by the polo 
gene  product  of Drosophila melanogaster (Sunkel  and 
Glover, 1988; Llamazares et al., 1991) and its putative ho- 
mologues Cdc5p of Saccharomyces cerevisiae (Kitada et al., 
1993), plol + of Schizosaccharomyces pombe (Ohkura et al., 
1995),  and  polo-like  kinase  1  (Plkl,  also  referred  to  as 
Plk) 1 of mouse and human (Clay et al., 1993; Lake and Jel- 
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inek, 1993; Golsteyn et al., 1994,  1995,  1996; Hamanaka 
et al., 1994; Holtrich et al., 1994). All these kinases exhibit 
a  high degree of sequence similarity, particularly within 
their  amino-terminally located catalytic domains. More- 
over, regions of sequence identity are also present within 
the carboxy-terminal noncatalytic domains, and a consen- 
sus motif comprising ,--~30 amino acids may constitute a 
characteristic signature of polo-like kinases (Clay et al., 
1993; Hamanaka et al. 1994; Golsteyn et al.; 1994, 1996). In 
addition to Plkl, two murine kinases more  distantly re- 
lated to Drosophila polo have also been discovered. These 
kinases,  termed  Snk  (Simmons  et  al.,  1992) and  Fnk 
(Donohue et al., 1995), are transcriptionally induced in re- 
sponse to mitogens, suggesting that they may play a role in 
progression through the G1 phase of the cell cycle. Thus, 
the  family of polo-like  kinases  may comprise  multiple 
members, at least in vertebrates, and it is an attractive pos- 
sibility that  different polo-like  kinases  may function at 
multiple stages of the cell cycle. Yet another polo-related 
murine kinase, termed Sak, is also thought to be involved 
in  mitotic and  meiotic cell division (Fode  et  al.,  1994). 
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its catalytic domain, it lacks the polo-consensus motif in 
the carboxy-terminal domain. 
The most detailed information about the properties and 
biological function of polo-like kinases has been obtained 
for Drosophila polo, the founding member of the family. 
During Drosophila development, increased levels of polo 
transcripts are observed in tissues with extensive mitotic 
activity,  and  polo protein  expression  appears  to  be  re- 
quired for all proliferative stages (Llamazares et al., 1991). 
In syncytial embryos, polo kinase activity was reported to 
peak during late anaphase-telophase (Fenton and Glover, 
1993),  and the  phenotype of polo mutants  strongly sug- 
gests a role for this kinase in mitosis (Sunkel and Glover, 
1988;  Llamazares  et  al.,  1991).  Drosophila  mutants  ho- 
mozygous for a strong mutant polo allele (polo  2) die as lar- 
vae.  However, flies with  a  weaker mutant  allele (polo  2) 
produce embryos unable  to undertake the  syncytial mi- 
totic cycles (Sunkel and Glover, 1988). These embryos dis- 
play condensed chromosomes associated with branched, 
highly irregular microtubule arrays,  and  they appear  to 
lack organized centrosomes (Sunkel and Glover, 1988). In 
larval neuroblasts, polo  1 mutants display a range of abnor- 
mal mitoses, which include overcondensed and polyploid 
chromosome complements and monopolar mitotic spindles. 
During male meiosis, chromosome disjunction is also dis- 
turbed (Sunkel and Glover, 1988; Llamazares et al., 1991). 
The putative yeast homologues of polo have also been 
studied by genetic approaches. In S. cerevisiae, mutations 
in the CDC5 gene produce abnormalities in both mitotic 
and  meiotic divisions  (Hartwell  et  al.,  1973;  Byers and 
Goetsch, 1974;  Schild and Byers 1980;  Sharon and Sim- 
chem, 1990).  CDC5 is essential for viability (Kitada et al., 
1993), and cdc5 mutants arrest in late mitosis as large, bud- 
ded, dumbbell-shaped cells, with partially segregated nu- 
clei on an elongated spindle (Kitada et al.,  1993). In the 
case of S. pombe, loss of plol + function has two distinct 
consequences: it leads to either a mitotic arrest in which 
condensed chromosomes are associated with a monopolar 
spindle or, following the completion of nuclear division, to 
a  failure in septation (Ohkura et al.,  1995). Overexpres- 
sion of wild-type plol ÷ results in the formation of mono- 
polar spindles and multiple septa, and, interestingly, multi- 
ple septa are formed even when plol ÷ is overexpressed in 
Gl-arrested cells (Ohkura et al., 1995). These results sug- 
gest that the fission yeast plol ÷ kinase may play a  dual 
role, being involved in both the establishment of a bipolar 
spindle and in septum formation. 
To what extent Drosophila polo, budding yeast Cdc5p, 
and  fission  yeast plol ÷ perform  exactly  corresponding 
functions is not clear at this time. Likewise, the biological 
role of vertebrate Plkl remains to be established, and as 
yet, information pertaining to mammalian Plkl function is 
mainly indirect.  Plkl  transcripts  are  highly expressed in 
tissues and cells exhibiting a high mitotic index (Clay et al., 
1993; Lake and Jelinek, 1993; Golsteyn et al.,  1994; Hol- 
trich et al.,  1994), including tumors and immortalized cell 
lines (Holtrich et al., 1994). Similar to budding yeast CDC5 
(Kitada et al., 1993), mammalian Plkl mRNA shows a cell 
cycle-dependent expression, accumulating to maximal lev- 
els during G2 and M phases (Lake and Jelinek, 1993; Lee 
et  al.,  1995).  Corresponding  cell  cycle oscillations  have 
also been observed for the Plkl protein (Golsteyn et al., 
1994,  1995; Hamanaka et al., 1995; Lee et al., 1995) and 
Plkl-associated  casein  kinase  activity  (Golsteyn  et  al., 
1995; Hamanaka et al., 1995; Lee et al., 1995). Most inter- 
estingly, Plkl associates with the mitotic spindle apparatus 
throughout mitosis (Golsteyn et al., 1994, 1995; Lee et al., 
1995).  Specifically, the  kinase  localizes to  spindle  poles 
during prophase and metaphase, redistributes to the spin- 
dle equatorial plane (the midzone) as cells enter anaphase, 
and finally, concentrates at the midbody during telophase 
(Golsteyn et al., 1994, 1995; Lee et al., 1995). 
The data described above support the view that verte- 
brate Plk may play a role during mitotic progression, much 
like its purported homologues in lower organisms. How- 
ever, we emphasize that data on the biological function of 
mammalian Plkl remain scarce, and there is no direct evi- 
dence for a mitotic role. Instead, results obtained with a 
sense-antisense RNA approach were interpreted to indi- 
cate  that  Plkl  functions  somehow  in  the  regulation  of 
DNA replication (Hamanaka et al., 1994). In these experi- 
ments,  microinjection of in  vitro transcribed Plkl  sense 
mRNA into serum-starved murine NIH 3T3 cells was re- 
ported to induce DNA synthesis, whereas full-length anti- 
sense RNA appeared to block thymidine incorporation in 
growing cells (Hamanaka et al., 1994). 
The goal of the present study was to directly explore the 
in vivo function of Plkl in human cells. To this end, highly 
specific anti-Plkl antibodies were microinjected into both 
immortalized (Hela) and nonimmortalized (Hs68) human 
cells at various stages of the cell cycle, and the ability of 
the injected cells to perform cell cycle functions was moni- 
tored. No evidence was obtained to support a role for Plkl 
in S phase progression. Instead, our data clearly demon- 
strate that Plkl function is required for both immortalized 
and  nonimmortalized ceils to proceed normally through 
mitosis. Cells injected with anti-Plkl antibodies displayed 
striking defects in their ability to assemble a bipolar spin- 
dle. As indicated by the use of antibodies against several 
centrosomal antigens,  these  defects most  probably arise 
from a failure of centrosomes to undergo critical structural 
changes  at the  G2 to M  transition.  Additional  roles for 
Plkl at later stages of mitosis are not excluded, although 
they could not be revealed by antibody microinjection. Fi- 
nally, microinjection of anti-Plkl  antibodies into nonim- 
mortalized Hs68 cells revealed that the majority of these 
cells failed to enter mitosis in the absence of Plkl function. 
This observation raises the intriguing possibility that the 
activation of Cdc2 kinase in nonimmortalized cells may de- 
pend on Plkl function and/or proper centrosome maturation. 
Materials and Methods 
Cell Culture, Synchronization, and Extraction 
Hs68 human foreskin fibroblasts were obtained from the American Type 
Culture Collection (Rockville, MD) and grown for not more than eight 
passages. All cells were cultured in DME (GIBCO BRL, Gaithersburg, 
MD) supplemented with 5% (HeLa) or 10%  (Hs68) FCS and penicillin- 
streptomycin (100 i.u./ml and 100 p.g/ml, respectively) at 37°C in 7% CO2. 
G0-arrested Hs68 fibroblasts were obtained by incubating 50% confluent 
cultures for 36 h in DME without FCS. After this period, <1% of the ceil 
population incorporated  bromodeoxyuridine (BrdU)  during an incuba- 
tion for 24 h, as detected by immunofluorescence microscopy (see below). 
This result correlated well with cell cycle analysis by flow cytometry, using 
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nocytometry Systems, Mountain  View, CA), which demonstrated that 
>95% of the cells presented a 2 N DNA content. To arrest exponentially 
growing HeLa cells at prometaphase, nocodazole (Sigma Chemical Co., 
St. Louis, MO) was added to a final concentration of 50 ng/ml for 17 h. Mi- 
totic cells were collected by mechanical shake-off, rinsed twice in pre- 
warmed medium, and replated in standard HeLa growth medium. To ar- 
rest  HeLa  cells  at  the  G1/S  boundary,  aphidicolin  (1  ~g/ml;  Sigma 
Chemical Co.) was added for 19 h. This treatment resulted in an accumu- 
lation of cells that were >80% arrested in late G1/early S phase with a 2 N 
DNA content, as assessed by flow cytometry. 
Cell extracts were prepared in NP-40 lysis buffer (50 mM Tris-HCI, pH 
8.0, 120 mM NaCI, 1% NP-40, 20 mM NaF, 1 mM EDTA, 5 mM EGTA, 
20 mM [3-glycerol phosphate, 0.1 mM PMSF, 10 I~g/ml leupeptin, 10 ~g/ml 
pepstatin A, 0.1 mM aprotinin) essentially as outlined in Golsteyn et al. 
(1995),  except that lysates were centrifuged at 12,000 g (4°C)  for 20 min 
immediately after extraction. Total  protein concentrations were deter- 
mined using the BioRad Protein Assay system (Hercules, CA) and BSA 
as a calibration standard. 
Iramunocheraical Techniques 
Anti-Plkl  lgG (Plkl ÷) were affinity purified from serum R32 as previ- 
ously  reported  (Golsteyn  et  al.,  1995).  A  negative  control  antibody 
(Plkl-) was prepared by passing the flow through the affinity column, de- 
pleted of all Plkl-specific antibodies, over a protein A-Sepharose column 
(Pharmacia LKB Biotechnology, Piscataway, N J) and eluting with 100 mM 
glycine-HCI, pH  3.0,  according to  manufacturers instructions. Purified 
Plkl ÷ and Plkl-  IgG preparations, as well as nonimmune IgG  (Sigma 
Chemical Co.), were dialyzed extensively against PBS, concentrated using 
a Centricon 30 unit (Amicon, Beverly, MA) and frozen in small aliquots at 
-70°C. Affinity-purified IgG specific for the human kinesin-related mo- 
tor protein HsEg5 (Eg5÷; Blangy et al., 1995) was also prepared as above. 
For immunoblotting, 10 Ixg of HeLa or Hs68 whole cell extracts or 3 ixg 
of an extract from Sf9 cells overexpressing recombinant Plkl  (see Gol- 
steyn et al., 1995) were resolved on a  10%  acrylamide SDS-PAGE gel, 
transferred to nitrocellulose membranes, and  incubated with Plkl + or 
Plkl- IgG (112 ng/ml in PBS containing 0.5% Tween 20), followed by al- 
kaline phosphatase-conjugated secondary antibodies (1/5,000 in PBS con- 
taining 0.5% Tween 20; Promega Corp., Madison, Wl), as previously de- 
scribed (Krek and Nigg, 1991). 
Microinjection and Immunofluorescence Microscopy 
For  microinjection of  asynchronous cells,  HeLa  and  Hs68  cells were 
grown on acid-washed coverslips until 50%  confluent and injected with 
antibodies  using  glass capillary  needles  (Clark  Electromedical Instru- 
ments, Reading, UK) pulled on a  micropipette puller (Flaming/Brown; 
Sutter Instruments Co., Novato, CA). Alternatively, ceils were injected 
after serum starvation for 30-36 h (Hs68 GO injections), after a nocoda- 
zole block and a 6-8 h release (HeLa G1 injections), or after an aphidi- 
colin block and a 5-6 h release (HeLa late S phase injections). All cover- 
slips were transferred into fresh medium shortly before injection of the 
appropriate IgG preparation (1.7 and 2 mg/ml for Plkl ÷ and Eg5 ÷ lgG, re- 
spectively, in 75%  PBS) into the cytoplasm of interphase or metaphase 
ceils. Injections were either clustered for DNA synthesis experiments or 
widely scattered (one cell per microscopic field) so that any effects on the 
ability of injected cells to divide could be clearly observed. After injection, 
coverslips were placed into fresh medium containing 5% FCS (for HeLa 
cells), 10%  FCS  (for Hs68  asynchronous injections), or 20%  FCS  (for 
Hs68 GO injections). For measurements of DNA synthesis, bromodeoxy- 
uridine/fluorodeoxyuridine  (Amersham  Corp.,  Arlington  Heights,  IL) 
was added to the medium (1/1,000)  for the duration of the experiment or 
for the times specified in the text. 
Cells were fixed at room temperature for 10 min with 3.7% formalde- 
hyde in PBS and permeabilized for 30 s with 100% acetone at -20°C. In- 
jected cells were located by incubating coverslips with biotinylated anti- 
rabbit IgG antibodies (1/50 in PBS containing 1% BSA [PBS/BSA]; Am- 
ersham Corp.) for 1 h, followed by a  mixture of Texas red-conjugated 
streptavidin (1/200  in PBS/BSA; Amersham Corp.) and Hoechst 33258 
(0.5 p~g/ml in PBS/BSA; Calbiochem-Novabiochem, La Jolla, CA) for 30 
min. For analysis of DNA synthesis, fixed and permeabilized cells were 
treated for 10 min at room temperature with 1.5 M HCI followed by ex- 
tensive washing with PBS. BrdU incorporation into nuclei was revealed as 
above, except that an anti-BrdU mouse mAb (Amersham Corp.) was used 
in the primary incubation, followed by FITC-conjugated anti-mouse lgG 
antibodies (Sigma Chemical Co.). 
For costaining of injected antibodies and microtubules, cells were first 
incubated with undiluted rat anti-tubulin YOL1/34 hybridoma superna- 
rant (Serotec Ltd., Oxford, UK) for 1 h, followed by biotinylated anti-rat 
lgG antibodies (1/100 in PBS/BSA; Amersham Corp.) for 30 min and, fi- 
nally, Texas red-conjugated streptavidin (1/200  in PBS/BSA), Hoechst 
33258 (0.5 ~g/ml in PBS/BSA), and FITC-conjugated anti-rabbit IgG an- 
tibodies (I/100 in PBS/BSA; Sigma Chemical Co.) for 30 min. For staining 
of centrosomes with the mouse mAb CTR453, cells were fixed either as 
above or in -20~C methanol for 6 min, as described previously (Bailly et 
al.,  1989).  For v-tubulin staining, a  rat antipeptide polyclonal antibody 
raised against a synthetic peptide (Joshi et al., 1992) was used, kindly pro- 
vided by Val Scott and Keith Gull (University of Manchester, UK), and 
cells were preextracted in  detergent and fixed as previously described 
(MacRae et al.,  1990). Before staining with the MPM-2 mAb, cells were 
preextracted before methanol fixation, as previously described (Vandr6 et 
al.,  1984). CTR453, ~/-tubulin,  and MPM-2 epitopes were revealed using 
the tubulin staining protocol, except that either CTR453 (diluted l/5 in 
PBS/BSA), -/-tubulin (diluted 1/~00 in PBS/BSA), or MPM-2 (diluted 1/ 
1,000 in PBS/BSA) antibodies were used for the primary incubation, fol- 
lowed by biotinylated anti-mouse or anti-rat IgG antibodies (1/50 in PBS/ 
BSA; Amersham Corp.). Coverslips were routinely mounted in 80% glyc- 
erol, 3% n-propyl gallate (in PBS), but were mounted in 90% glycerol, 
I00 mM Tris-HCl, pH 9.0, for DNA synthesis experiments. Cells were ob- 
served with a microscope (Axiophot; Carl Zeiss, Inc., Thornwood, NY) 
using 63 or 100x oil immersion objectives. In some cases, confocal laser 
scanning microscopy was performed on an invert laser scan microscope 
(model LSM 410; Carl Zeiss, Inc.), with a 63× plan-APOCHROMAT oil 
immersion objective, according to manufacturers instructions. Excitation 
wavelengths used were 488  nm for FITC (argon laser) and 543  nm for 
Texas red (helium/neon laser), with absorption windows of 510--525 nm 
and >570 nm, respectively. Confocal images presented in this paper rep- 
resent projections of Z-series scans. 
Results 
A Polyclonal  Antibody Highly Specific  for Plkl in HeLa 
and Hs68 Cells 
A rabbit polyclonal antibody (R32) was raised against the 
carboxy-terminal 202  amino acids of human Plkl  (Gol- 
steyn et al., 1995). For the purpose of the present microin- 
jection study, Plkl-specific IgG (Plkl +) were affinity puri- 
fied  from  R32  serum.  As  a  control,  nonspecific  IgG 
(Plkl-) were prepared from the flow through of the affin- 
ity column. The  specificity of these  reagents is demon- 
strated in Fig. 1 (see also Golsteyn et al., 1995). Upon im- 
munoblotting, Plkl + decorated a single N66-kD protein in 
asynchronous HeLa and Hs68 cell extracts (Fig. 1, lanes 2 
and 3). This protein comigrated exactly with recombinant 
Plkl  expressed  in  baculovirus-infected  Sf9  insect  cells 
(lane 1). It is noteworthy that the expression level of Plkl 
protein was approximately twofold lower in Hs68 than in 
HeLa cells (compare lanes 2  and 3), probably reflecting 
the lower mitotic index of nonimmortalized cell popula- 
tions. Also, no Plkl protein could be detected in extracts 
derived from G0-arrested Hs68 cells (Jane 4), consistent 
with previous analyses of Plkl mRNA levels (Lake and Jel- 
inek,  1993; Holtrich et  al.,  1994; Lee et  al.,  1995).  The 
Plkl-  IgG did not recognize Plkl in any of the samples 
(Fig. 1, lanes 5-7), indicating that this preparation had in- 
deed been successfully depleted of all Plkl-specific anti- 
bodies and could thus be used as an innocuous control. 
Plkl ÷ InJection Does Not Affect DNA Synthesis in 
HeLa or Hs68 Cells 
On the basis of antisense experiments, Plkl had previously 
Lane and Nigg Mitotic Function  of  Human Polo-like Kinase 1  1703 Figure I.  Specificity  of the Plkl ~" antibody. Extracts of Sf9 cells 
expressing recombinant Plkl (lanes I and 5), asynchronous HeLa 
cells (lanes 2 and 6), asynchronous Hs68 cells (lanes 3 and 7), and 
GO serum-arrested  Hs68 cells  (lanes 4 and 8) were resolved by 
SDS-PAGE, transferred to nitrocellulose, and probed with Plkl ÷ 
(lanes 1-4) or Plkl- (lanes 5-8) IgG. Molecular mass standards 
are indicated on the left. 
been  implicated  in  the  control of DNA  replication  (Ha- 
manaka  et al.,  1994). Therefore, we wished  to determine 
whether  microinjection  of Plkl-specific  antibodies  would 
interfere  with  DNA  synthesis.  Equal  concentrations  of 
Plkl ÷ and Plkl- IgG (1.7 mg/ml) were injected into the cy- 
toplasm  of  both  asynchronous  HeLa  and  G0-arrested 
Hs68  cells.  Then,  BrdU  was  added  to  the  injected  cells, 
and these were either further cultured for 20 h  (HeLa) or 
released into the cell cycle by readdition of serum for 40 h 
(Hs68). After fixation, the ability of injected cells to incor- 
porate BrdU into nuclei was assessed using an anti-BrdU 
mAb for indirect immunofluorescence microscopy. In both 
cell  types,  very similar  proportions  of cells  had  incorpo- 
rated BrdU, regardless of whether they had been injected 
with Plkl ÷ or Plkl- antibodies, or had not been injected at 
all (Fig. 2 A). 
The above experiment argued that Plkl ÷ antibodies did 
not  block  DNA  synthesis,  but  it  remained  possible  that 
they might have influenced the kinetics of either entry into 
or  exit  from  S  phase.  To  examine  this  possibility,  both 
HeLa and Hs68 cells  were synchronized before injection 
with  Plkl ÷  antibodies.  HeLa  cells  were  arrested  in  pro- 
metaphase with nocodazole and then released and micro- 
injected in the subsequent  early G1 phase.  Hs68 cells, on 
the other hand, were arrested  in GO by serum starvation 
and then injected and released into the celt cycle by serum 
readdition. In both cases, entry into and exit from S phase 
were monitored by pulse labeling with BrdU. The results, 
summarized  in  Fig.  2  B, clearly show that  cells  microin- 
jected  with  Plkl ÷  entered  and  exited  S  phase  with  the 
same  kinetics  as  the  surrounding,  noninjected  cells.  We 
conclude, therefore, that injection of Plkl-specific IgG has 
no effect on the ability of either HeLa or Hs68 cells to pro- 
ceed through S phase. These results lend no support to the 
proposition that Plkl  plays a  role in S phase events  (Ha- 
manaka et al., 1994; see Discussion). 
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Figure 2.  Plkl + injection has no effect on S phase progression in 
HeLa or Hs68 cells. (A) Asynchronously growing HeLa cells, and 
Hs68 ceils induced to withdraw from the cell cycle by serum dep- 
rivation (GO), were microinjected into the cytoplasm with Plkl* 
or Plkt - IgG. Upon continued incubation (HeLa) or release into 
the  cell  cycle by serum  readdition  (Hs68), in  the  presence  of 
BrdU, the cells were analyzed by immunofluorescence after 20 
and  40  h,  respectively.  The  percentage  of cells  incorporating 
BrdU into nuclei is presented. Results are averages with standard 
deviations derived from three (HeLa) and two (Hs68) indepen- 
dent experiments. A total of 227 (HeLa) and 85 (Hs68) cells were 
injected with Plkl +, and 134 (HeLa) and 70 (Hs68) cells were in- 
jected with Plkl-. (B) HeLa cells synchronized in G1 by nocoda- 
zole release and Hs68 arrested in GO were injected with Plkl + 
IgG. Upon continued  incubation  (HeLa) or  serum  readdition 
(Hs68), cells  were pulse-labeled  with BrdU for the times indi- 
cated  and  then  analyzed  by  immunofluorescence  microscopy. 
The percentage of cells  incorporating BrdU into nuclei  during 
the pulse time is presented.  At least 40 cells  were injected for 
each time point. 
Plkl + Injection into HeLa Cells Interferes with Mitotic 
Progression  and Cell Division 
During the course of the experiments described above, we 
had noticed a  build-up of rounded, mitotic-like ceils after 
Plkl +  injection.  To  investigate  the  possibility  that  Plkl 
might be required for progression through mitosis, we es- 
tablished  a  protocol of scattered  microinjection,  Accord- 
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Figure I.  Specificity  of the Plkl + antibody. Extracts of Sf9 cells 
expressing recombinant Plkl (lanes I and 5), asynchronous HeLa 
cells (lanes 2 and 6), asynchronous Hs68 cells (lanes 3 and 7), and 
GO serum-arrested  Hs68 cells  (lanes 4 and 8) were resolved by 
SDS-PAGE, transferred to nitrocellulose, and probed with Plkl + 
(lanes 1-4) or Plkl- (lanes 5-8) IgG. Molecular mass standards 
are indicated on the left. 
been  implicated  in  the  control of DNA  replication  (Ha- 
manaka  et al.,  1994). Therefore, we wished  to determine 
whether  microinjection  of Plkl-specific  antibodies  would 
interfere  with  DNA  synthesis.  Equal  concentrations  of 
Plkl ÷ and Plkl- IgG (1.7 mg/ml) were injected into the cy- 
toplasm  of  both  asynchronous  HeLa  and  G0-arrested 
Hs68  cells.  Then,  BrdU  was  added  to  the  injected  cells, 
and these were either further cultured for 20 h  (HeLa) or 
released into the cell cycle by readdition of serum for 40 h 
(Hs68). After fixation, the ability of injected cells to incor- 
porate BrdU into nuclei was assessed using an anti-BrdU 
mAb for indirect immunofluorescence microscopy. In both 
cell  types,  very similar  proportions  of cells  had  incorpo- 
rated BrdU, regardless of whether they had been injected 
with Plkl + or Plkl- antibodies, or had not been injected at 
all (Fig. 2 A). 
The above experiment argued that Plkl ÷ antibodies did 
not  block  DNA  synthesis,  but  it  remained  possible  that 
they might have influenced the kinetics of either entry into 
or  exit  from  S  phase.  To  examine  this  possibility,  both 
HeLa and Hs68 cells  were synchronized before injection 
with  Plkl ÷  antibodies.  HeLa  cells  were  arrested  in  pro- 
metaphase with nocodazole and then released and micro- 
injected in the subsequent  early G1 phase.  Hs68 cells, on 
the other hand, were arrested  in GO by serum starvation 
and then injected and released into the celt cycle by serum 
readdition. In both cases, entry into and exit from S phase 
were monitored by pulse labeling with BrdU. The results, 
summarized  in  Fig.  2  B, clearly show that  cells  microin- 
jected  with  Plkl +  entered  and  exited  S  phase  with  the 
same  kinetics  as  the  surrounding,  noninjected  cells.  We 
conclude, therefore, that injection of Plkl-specific IgG has 
no effect on the ability of either HeLa or Hs68 cells to pro- 
ceed through S phase. These results lend no support to the 
proposition that Plkl  plays a  role in S phase events  (Ha- 
manaka et al., 1994; see Discussion). 
Figure 2.  Plkl + injection has no effect on S phase progression in 
HeLa or Hs68 cells. (A) Asynchronously growing HeLa cells, and 
Hs68 ceils induced to withdraw from the cell cycle by serum dep- 
rivation (GO), were microinjected into the cytoplasm with Plkl ~ 
or Plkt - IgG. Upon continued incubation (HeLa) or release into 
the  cell  cycle by serum  readdition  (Hs68), in  the  presence  of 
BrdU, the cells were analyzed by immunofluorescence after 20 
and  40  h,  respectively.  The  percentage  of cells  incorporating 
BrdU into nuclei is presented. Results are averages with standard 
deviations derived from three (HeLa) and two (Hs68) indepen- 
dent experiments. A total of 227 (HeLa) and 85 (Hs68) cells were 
injected with Plkl +, and 134 (HeLa) and 70 (Hs68) cells were in- 
jected with Plkl-. (B) HeLa cells synchronized in G1 by nocoda- 
zole release and Hs68 arrested in GO were injected with Plkl + 
IgG. Upon continued  incubation  (HeLa) or  serum  readdition 
(Hs68), cells  were pulseqabeled  with BrdU for the times indi- 
cated  and  then  analyzed  by  immunofluorescence  microscopy. 
The percentage of cells  incorporating BrdU into nuclei  during 
the pulse time is presented.  At least 40 cells  were injected for 
each time point. 
Plkl + Injection into HeLa Cells Interferes with Mitotic 
Progression  and Cell Division 
During the course of the experiments described above, we 
had noticed a  build-up of rounded, mitotic-like ceils after 
Plkl +  injection.  To  investigate  the  possibility  that  Plkl 
might be required for progression through mitosis, we es- 
tablished  a  protocol of scattered  microinjection,  Accord- 
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injected, and the fate of each cell is then monitored as a 
function of time. In a first series of experiments, Plkl + or 
control antibodies were microinjected into the cytoplasm 
of asynchronously growing HeLa cells, and after incuba- 
tion for 20 or 40 h, cells were analyzed by fluorescence mi- 
croscopy using secondary antibodies to visualize injected 
cells and Hoechst dye to monitor the state of the DNA. 
The results of these experiments are summarized in Fig. 3 
and Table I. Of the Plkl--injected cells, >90% proceeded 
through mitosis to the two cell stage by 20 h, with only 
very few cells in mitosis  (<1%),  and with  no significant 
proportion of abnormal phenotypes evident. After 40 h, 
most of these cells had proceeded through a second round 
of division, reaching the four cell stage (Fig. 3 A and Table I). 
Identical results were obtained after injection of a nonim- 
mune IgG control (Table I). In contrast, only 30% of the 
cells injected with  Plkl + had divided normally by 20 h, 
while 34% accumulated as rounded, mitotic-like cells (Ta- 
ble I). Hoechst staining of these cells revealed condensed, 
ball-like chromosomes that, in most cases, exhibited no 
obvious alignment in a metaphase plate (Fig. 3 B, a). Some 
25%  of the  cells  displayed  additional  abnormal  pheno- 
types  (Fig.  3  B  and Table I).  These included cells with 
strikingly fragmented nuclei  (referred to as micronuclei; 
Fig. 3 B, b) or with multiple nuclei of unknown karyotype 
(Fig. 3 B, c), and cells that had undergone inappropriate 
nuclear  division,  as  characterized  by the  appearance  of 
DNA strands between divided cells (Fig. 3 B, d). By 40 h 
after injection of Plkl ÷, the number of abnormal mitotic 
cells had dropped to 5%, with a concomitant increase in 
the number of micronucleated and multinucleated cells to 
40% (Table I). 
The described phenotypes suggested a function for Plkl 
specifically during mitosis.  One could legitimately argue, 
however, that Plkl  might actually be required earlier in 
the  cell cycle, for example during S phase when centro- 
somes  are duplicated,  but  that  the consequences of im- 
paired Plkl  function might only become apparent in the 
subsequent mitosis. To rule out this possibility, HeLa cells 
were synchronized at the G1/S border, using aphidicolin, 
and Plkl ÷ or Plkl- IgG were injected 5-6 h after release 
from this block, i.e., when cells were in late S phase/early 
G2 (as assessed by flow cytometry; data not shown). After 
an additional incubation for 7, 14, or 24 h, cells were fixed 
and  their  mitotic  index  and  ability  to  divide  recorded 
(Fig. 4). By 13 h after the release from the G1/S block, the 
time at which we found the wave of mitotic cells to reach 
its highest level in the control samples, 23 and 19% of non- 
injected and Plkl--injected cells, respectively, were in mi- 
tosis (Fig. 4 A). At this early time, the number of Plkt + 
cells in mitosis was  somewhat reduced (14%; Fig.  4 A), 
and comparatively few of the injected ceils had completed 
division (19% for Plkl- and 12% for Plkl+; Fig. 4 B). The 
impairment of Plkl function did, however, produce strik- 
ing effects by 20 h; at this time, 77% of Plkl--injected cells 
had divided (Fig. 4 B), and, concomitantly, the mitotic in- 
dex of these as well as the surrounding noninjected cells 
was strongly reduced (Fig. 4 A). In marked contrast, com- 
paratively few of the Plkl+-injected cells (26%) had com- 
pleted division (Fig. 4 B), and instead, many (45%) had ac- 
cumulated as rounded, mitotic-like cells (Fig. 4 A). After 
30 h, virtually all Ptkl--injected cells had completed divi- 
sion (87%), but there was no significant further increase in 
the number of Plkl+-injected cells that had divided (29%; 
Fig.  4  B).  At  this  late  time,  up  to  50%  of the  Plkl +- 
injected cells were either micronucleated or multinucle- 
ated (data not shown). From the data shown in this sec- 
tion,  we  conclude  that  abrogation  of  Plkl  function  in 
HeLa cells  results  in  a  strong  inhibition of progression 
through mitosis, which ultimately culminates in a lack of 
cytokinesis and a  failure to segregate chromosomes cor- 
rectly. 
Microinjection of Plkl + into HeLa Cells Leads to 
Nucleation of Abnormal Microtubule Arrays from 
Small, Duplicated but Unseparated Centrosomes 
As a first step towards understanding the molecular basis 
for the observed requirement for Plkl function during mi- 
tosis, Plkl+-injected, mitotically blocked cells (of the type 
shown in Fig. 3 B, a) were analyzed by confocal and con- 
ventional microscopy, using antitubulin  and antipericen- 
trosomal mAbs  for immunofluorescent staining  (Fig. 5). 
Whereas Plkl--injected cells were able to set up a normal 
bipolar spindle (Fig. 5 A, left), most of the Plkl+-injected 
cells failed to do so. Instead, 68% of all mitotic cells exam- 
ined displayed arrays of comparatively thin microtubule 
bundles nucleating from a single organizing center, more 
reminiscent of interphase microtubules than of spindle fi- 
bres (Fig. 5 A, right). Structures resembling bipolar spin- 
dles could be observed in the remaining cells, but only few 
of these looked completely normal (data not shown). 
Colocalization of microtubules and the CTR453 antigen, 
a pericentrosomal protein (Bailly et al., 1989), revealed that 
the  monoastral  microtubule arrays frequently contained 
two centrosomes that had clearly duplicated but had failed 
to separate sufficiently for bipolar spindle formation (Fig. 
5 B, left). At first glance, this phenotype appears similar to 
that previously observed after microinjection of antibodies 
against  HsEg5,  a  centrosome-associated,  kinesin-related 
motor protein  (Blangy et al.,  1995).  However, although 
centrosome separation was indeed inhibited in both cases, 
a direct comparison of the phenotypes induced by Plkl ÷ 
or anti-HsEg5 antibodies (Eg5 ÷) revealed striking differ- 
ences:  compared  to  Eg5+-injected  cells,  Plkl+-injected 
cells displayed much smaller centrosomes, and the density 
of microtubules  nucleating  from these  centrosomes  ap- 
peared to be decreased (Fig 5 B, compare left and right). 
To confirm the  apparent  reduction in  centrosome size, 
HeLa cells were  injected in  the  exact same  experiment 
with Plkl ÷ or Eg5 ÷ IgG's. After 20 h, centrosomes were 
stained  with CTR453 and the sizes of centrosomes were 
recorded using conventional  ~  fluorescence microscopy and 
identical photographic conditions.  As  can be seen from 
Fig.  5  C,  the  centrosomes in  Eg5+-injected cells (right) 
were indistinguishable in their sizes from those of unin- 
jected mitotic HeLa cells (left), whereas those of Plkl +- 
injected cells were substantially reduced in size (middle). 
These data indicate that Plkl function is required for cen- 
trosomes to undergo a functional maturation that is typi- 
cally reflected by an apparent increase in centrosome size 
(Vorobjev and Nadehzdina, 1987; Kimble and Kuriyama, 
1992; Kalt and Schliwa, 1993). 
Lane and Nigg Mitotic Function of Human Polo-like Kinase 1  1705 Figure  3.  Injection of HeLa 
cells with Plkl + inhibits mi- 
totic progression and causes 
abnormal  division  pheno- 
types.  Widely  scattered 
HeLa  cells  were  injected 
with  Plkl  ÷  or  Plkl-  IgG, 
fixed, and analyzed by immu- 
nofluorescence  microscopy 
after 20 and 40 h of incuba- 
tion.  (A)  Plkl-  control- 
injected ceils showing normal 
progression through the first 
(20 h) and second (40 h) cell 
division. (B)  Commonly ob- 
served  phenotypes  caused 
by Plkl + injection: rounded 
mitotic  cells  with  ball-like 
DNA  condensation (a),  mi- 
cronucleated interphase cells 
(b),  multinucleated  inter- 
phase  ceils  (c),  and divided 
cells still connected by a DNA 
strand (d). Bars, 10 izm. 
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Antibody injected  Plk  1  +  Plk  I -  Nonimmune IgG 
20 h  % 
Single interphase cells  11  (32/291)* 
Normally divided cells  30  (87/291) 
Mitotic cells*  34  (98/291) 
Micro-/Multinucleated cells  20  (58/291) 
Divided cells with connecting 
DNA strand  5  (161291) 
Total  1  O0 
40 h 
Single interphase cells  1  (2/201) 
Normally divided cells  §  51  ( 102/201 ) 
Mitotic cells*  5  ( 10/201 ) 
Micro-/Multinucleated cells  40  (81/201 ) 
Divided cells with connecting 
DNA strand  3  (6/201) 
Total  100 
%  % 
3  (5/147)  4  (8/191) 
94  (138/147)  92  (176/191) 
0.5  (1/147)  1  (2/191) 
2.5  (4/147)  2  (4/191) 
(0/147)  1  (1/191) 
100  100 
1  (1/78)  0  (0/66) 
91  (71/78)  94  (62/66) 
0  (0/78)  0  (0/66) 
8  (6/78)  6  (4/66) 
0  (0/78)  0  (0/66) 
100  100 
Asynchronously growing interphase HeLa cells were microinjected with Plk  1  +, Plkl  , or nonimmune IgG. After 20 and 40 h incubation, cells were fixed and analyzed by immu- 
nofluorescence microscopy. Microscopic scanning of the glass coverslip allowed the calculation of the percentage of injected cells with the phenotypes listed. The total results of 
four independent experiments with the appropriate  controls are shown. 
* MitoUc cells injected with Plkl  + display abnormal DNA condensation  as described in the text (see also Fig. 3 B, a). 
Total number of cells displaying  phenotype/total  number of injected cells. 
~Cells that have gone through at least one normal cell division. For simplicity,  ceils that have divided once or twice are grouped together.  In contro[-injeeted  cells, at least 80% 
have gone to the four ceil stage. 
Plkl + Injection Inhibits the Recruitment of y-Tubulin 
and MPM-2 Epitopes to Mitotic Centrosomes 
To analyze the centrosome maturation defect in more de- 
tail, HeLa cells were injected with either Plkl + or Eg5 + 
IgG's and 20 h later were stained with antibodies recogniz- 
ing either "y-tubulin  (Fig.  6 A)  or the  MFM-2  phospho- 
epitope  (Fig. 6 B). ~/-Tubulin is a  highly conserved cen- 
trosomal  protein  required  for  microtubule  nucleation 
(Oakley and Oakley, 1989; Oakley et al., 1990; Steams et al., 
1991; Zheng et al., 1991, Joshi et al., 1992; F61ix et al., 1994; 
Stearns and Kirschner, 1994; Shu and Joshi, 1995; Sunkel 
et al., 1995; Moritz et al., 1995a,b), whereas MPM-2 immu- 
noreactivity appears  on multiple proteins  upon  entry of 
cells into mitosis (Davis et al.,  1983; Vandr6 et al., 1991), 
most prominently on mitotic spindle poles (Vandr6 et al., 
1984, 1986, 1991). Thus, in HeLa cells the accumulation of 
both -y-tubulin and MPM-2 immunoreactivity can be con- 
sidered as excellent markers for the functional maturation 
of centrosomes at the G2 to M transition. 
In line with previous results (Zheng et al., 1991; Lajoie- 
Mazenc et al.,  1994), we found that centrosome staining 
with anti-'y-tubulin antibodies was comparatively weak in 
interphase HeLa cells, but increased substantially as cells 
entered  mitosis  (Fig.  6  A,  compare  left panels).  Within 
monoastral  spindles  of  Plkl+-injected  cells,  the  cen- 
trosomes displayed very weak "¥-tubulin  staining, reminis- 
cent of interphase cells, whereas in Eg5 + injected mitotic 
cells, staining was as intense as in noninjected mitotic cells 
(Fig 6 A, compare right panels). Although the lack of im- 
munoreactivity cannot be considered as rigorous proof for 
the absence of the corresponding antigen, the most likely 
interpretation of these results is that, during the G2 to M 
transition, Plkl + antibodies specifically inhibited the re- 
cruitment of ~/-tubulin to centrosomes, whereas Eg5 + anti- 
bodies were without effect. Next, we investigated whether 
the injection of Plkl +, or Eg5 + for control, would interfere 
with the appearance of MPM-2 reactivity. 20 h after injec- 
tion, HeLa cells were stained with MPM-2 (Fig. 6 B, up- 
per) and, for comparison, with antibodies against et-tubu- 
lin (Fig. 6 B, lower). In agreement with previous results 
(Vandr6  et  al.,  1984,  1986,  1991),  the  MPM-2  antibody 
stained  spindle  poles and spindle  microtubules in HeLa 
cells; in addition, it stained a number of dots in the spindle 
mid-zone, most likely representing kinetochores (Fig. 6 B, 
upper left).  After injection of Plkl + antibodies, however, 
MPM-2 reactivity was rearranged. Most typically, spindle 
poles showed little if any staining, and instead, MPM-2 re- 
activity was confined to surrounding microtubules (Fig. 6 
B,  upper  middle).  In  contrast,  MPM-2  reactivity  could 
readily be discerned on the duplicated centrosomes as well 
as on the astral microtubules in Eg5+-injected cells (Fig. 6 
B, upper right). We reproducibly observed also that kineto- 
chore staining  by MPM-2  antibodies was  impaired after 
the microinjection of Plkl + but not Eg5 + antibodies, al- 
though  this  result  is  very difficult to  document  photo- 
graphically (see Fig. 6 B). These latter data indicate that 
the accumulation of MPM-2 reactivity at centrosomes, and 
possibly  at  kinetochores,  is  inhibited  by  Plkl +  but  not 
Eg5 + antibodies. 
Plkl + Injection Blocks Entry into Mitosis in 
Noniramortalized Hs68 Fibroblasts 
As many immortalized tumor cell lines, including HeLa, 
are known to be defective in cell cycle checkpoint func- 
tions (Hartwell and Weinert, 1989; Murray, 1992; Hartwell 
and Kastan, 1994), we considered it important to extend 
our studies to diploid, nonimmortalized human cells. Spe- 
cifically, we examined the effects of Plkl + injection on the 
cell cycle progression of human foreskin fibroblasts (Hs68). 
Plkl + and Plkl- IgG were injected into the cytoplasm of 
widely scattered, asynchronously growing interphase Hs68 
cells, and 36 or 48 h later, cells were fixed and examined 
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Figure 4.  Plkl ÷ injection of HeLa cells in late S phase inhibits mi- 
totic progression.  HeLa cells, synchronized  at G1/S by aphidi- 
colin treatment, were released into the cell cycle for 5-6 h before 
Plkl ÷ or Plkl-  injection  into the cytoplasm;  at that time, they 
were in late S/early G2 phase. Injections were scattered for accu- 
rate counting,  and upon continued  incubation,  cells were fixed 
and analyzed  by immunofluorescence  microscopy at the times 
(post G1/S release) indicated.  Indicated are in (A) the mitotic in- 
dex (i.e., the percentage of cells showing chromosome condensa- 
tion) and in  (B) the percentage of injected  cells that had pro- 
ceeded through one cell division. At least 30 cells were injected 
for each time point in each experiment, and the averages of three 
independent experiments with standard deviations are shown. 
microscopically. Whereas 52 and 67% of the Plkl--injected 
cells had divided normally after 36 and 48 h, respectively, 
with  no  abnormal  phenotypes  evident,  only  5%  of the 
Plkl+-injected cells had progressed to the two cell stage by 
these  times  (Table  II).  Furthermore,  only  16%  of  the 
Plkl+-injected cells had accumulated as rounded, mitotic- 
like  cells  by 36  h  (Table  II). These  abnormal  cells  dis- 
played the same ball-like chromatin condensation as seen 
with HeLa cells (Fig. 7 A, right). Further analysis of these 
cells  by  immunofluorescence  and  confocal  microscopy 
demonstrated a complete absence of bipolar mitotic spin- 
dles  (Fig.  7 A,  left).  Centrosomes,  although  duplicated, 
were unseparated  and  drastically reduced  in  size, as  de- 
scribed above for HeLa cells (data not shown). By 48 h, 
the number of mitotically blocked cells decreased to 2%, 
with a  concomitant increase  in  the  proportion  of micro- 
and multinucleated cells (from 8 to 18%; Table II), consis- 
tent with the idea that these late phenotypes may repre- 
sent the end result of aborted mitoses. 
These  results  show  that  Plkl +  antibody injection  into 
Hs68 cells could produce aberrant mitotic phenotypes that 
were qualitatively similar to those observed in HeLa cells. 
Rather unexpectedly, however, we found that the vast ma- 
jority of the Plkl+-injected Hs68 cells (75%) persisted as 
single, interphase cells with apparently normal interphase 
microtubule networks. As shown in Fig. 7 B, these Plkl +- 
injected cells displayed duplicated  centrosomes (middle), 
the sizes of which were comparable to those of uninjected 
interphase cells (left),  but significantly smaller than those 
of mitotic cells (right). It would seem, therefore, that most 
of the Plkl+-injected Hs68 cells did not even attempt en- 
tering mitosis, but  instead  arrested in  late interphase.  In 
comparison,  only 32%  of Plkl--injected  Hs68  cells,  and 
only 1%  of Plkl+-injected HeLa cells, persisted as single 
cells  (Tables  I  and  II).  One  intriguing  interpretation  of 
these results is that nonimmortalized cells contain a check- 
point  monitoring  the  proper  maturation  of centrosomes 
(see Discussion). 
Plkl ÷ Injection Does Not Affect Mitotic Events 
Subsequent to Bipolar Spindle Formation 
In a  final series of experiments, we  asked whether  Plkl 
function might also be essential during later stages of mi- 
tosis,  particularly  during  cytokinesis.  To  this  end,  Plkl + 
and Plkl- IgG were injected into cells that had already es- 
tablished a  mitotic spindle. These were selected amongst 
exponentially growing HeLa and Hs68 cells, using phase 
contrast  microscopy to  identify  cells with  clearly visible 
metaphase chromosomes. After  15-20 h,  87 and  97%  of 
control-injected HeLa and Hs68 cells had completed cy- 
tokinesis and proceeded to the two-cell stage, respectively 
(Table  III). Remarkably, a  similar percentage  of Plkl +- 
injected  cells  (88  and  91%  of HeLa  and  Hs68,  respec- 
tively) had also divided, with no significant percentages of 
cells displaying  abnormal phenotypes  (Table  III). These 
results indicate that Plkl function is no longer sensitive to 
inhibition  by microinjected  antibodies  beyond the  meta- 
phase state. They do not prove that Plkl is not involved in 
later stages of mitosis (see Discussion), but they provide 
an  exquisite  control  and  attest  to  the  specificity  of the 
block to mitotic progression observed after antibody injec- 
tion into interphase cells. 
Discussion 
In  this  study,  we  have  explored  the  function  of human 
Plkl, using highly specific anti-Plkl antibodies for micro- 
injection  experiments. We have obtained no evidence to 
support a  role for Plkl  during DNA replication.  Instead, 
our data clearly establish that Plkl function is required for 
progression  through  mitosis.  A  detailed  analysis  of the 
phenotypes of antibody-injected cells indicates that mam- 
malian Plkl  is required  for the  functional  maturation of 
centrosomes, and hence for the assembly of a bipolar spin- 
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Figure 4.  Plkl ÷ injection of HeLa cells in late S phase inhibits mi- 
totic progressiorL HeLa cells, synchronized  at G1/S by aphidi- 
colin treatment, were released into the cell cycle for 5-6 h before 
Plkl ÷ or Plkl-  injection  into the cytoplasm;  at that time, they 
were in late S/early G2 phase. Injections were scattered for accu- 
rate counting,  and upon continued  incubation,  cells were fixed 
and analyzed  by immunofluorescence  microscopy at the times 
(post G1/S release) indicated.  Indicated are in (A) the mitotic in- 
dex (i.e., the percentage of cells showing chromosome condensa- 
tion) and in  (B) the percentage of injected  cells that had pro- 
ceeded through one cell division. At least 30 cells were injected 
for each time point in each experiment, and the averages of three 
independent experiments with standard deviations are shown. 
microscopically. Whereas 52 and 67% of the Plkl--injected 
cells had divided normally after 36 and 48 h, respectively, 
with  no  abnormal  phenotypes  evident,  only  5%  of the 
Plkl+-injected cells had progressed to the two cell stage by 
these  times  (Table  II).  Furthermore,  only  16%  of  the 
Plkl+-injected cells had accumulated as rounded, mitotic- 
like  cells  by 36  h  (Table  II). These  abnormal  cells  dis- 
played the same ball-like chromatin condensation as seen 
with HeLa cells (Fig. 7 A, right). Further analysis of these 
cells  by  immunofluorescence  and  confocal  microscopy 
demonstrated a complete absence of bipolar mitotic spin- 
dles  (Fig.  7 A,  left).  Centrosomes,  although  duplicated, 
were unseparated  and  drastically reduced  in  size, as  de- 
scribed above for HeLa cells (data not shown). By 48 h, 
the number of mitotically blocked cells decreased to 2%, 
with a  concomitant increase  in  the  proportion  of micro- 
and multinucleated cells (from 8 to 18%; Table II), consis- 
tent with the idea that these late phenotypes may repre- 
sent the end result of aborted mitoses. 
These  results  show  that  Plkl +  antibody injection  into 
Hs68 cells could produce aberrant mitotic phenotypes that 
were qualitatively similar to those observed in HeLa cells. 
Rather unexpectedly, however, we found that the vast ma- 
jority of the Plkl+-injected Hs68 cells (75%) persisted as 
single, interphase cells with apparently normal interphase 
microtubule networks. As shown in Fig. 7 B, these Plkl +- 
injected cells displayed duplicated  centrosomes (middle), 
the sizes of which were comparable to those of uninjected 
interphase cells (left),  but significantly smaller than those 
of mitotic cells (right). It would seem, therefore, that most 
of the Plkl+-injected Hs68 cells did not even attempt en- 
tering mitosis, but  instead  arrested in  late interphase.  In 
comparison,  only 32%  of Plkl--injected  Hs68  cells,  and 
only 1%  of Plkl+-injected HeLa cells, persisted as single 
cells  (Tables  I  and  II).  One  intriguing  interpretation  of 
these results is that nonimmortalized cells contain a check- 
point  monitoring  the  proper  maturation  of centrosomes 
(see Discussion). 
Plkl ÷ Injection Does Not Affect Mitotic Events 
Subsequent to Bipolar Spindle Formation 
In a  final series of experiments, we  asked whether  Plkl 
function might also be essential during later stages of mi- 
tosis,  particularly  during  cytokinesis.  To  this  end,  Plkl + 
and Plkl- IgG were injected into cells that had already es- 
tablished a  mitotic spindle. These were selected amongst 
exponentially growing HeLa and Hs68 cells, using phase 
contrast  microscopy to  identify  cells with  clearly visible 
metaphase chromosomes. After  15-20 h,  87 and  97%  of 
control-injected HeLa and Hs68 cells had completed cy- 
tokinesis and proceeded to the two-cell stage, respectively 
(Table  III). Remarkably, a  similar percentage  of Plkl +- 
injected  cells  (88  and  91%  of HeLa  and  Hs68,  respec- 
tively) had also divided, with no significant percentages of 
cells displaying  abnormal phenotypes  (Table  III). These 
results indicate that Plkl function is no longer sensitive to 
inhibition  by microinjected  antibodies  beyond the  meta- 
phase state. They do not prove that Plkl is not involved in 
later stages of mitosis (see Discussion), but they provide 
an  exquisite  control  and  attest  to  the  specificity  of the 
block to mitotic progression observed after antibody injec- 
tion into interphase cells. 
Discussion 
In  this  study,  we  have  explored  the  function  of human 
Plkl, using highly specific anti-Plkl antibodies for micro- 
injection  experiments. We have obtained no evidence to 
support a  role for Plkl  during DNA replication.  Instead, 
our data clearly establish that Plkl function is required for 
progression  through  mitosis.  A  detailed  analysis  of the 
phenotypes of antibody-injected cells indicates that mam- 
malian Plkl  is required  for the  functional  maturation of 
centrosomes, and hence for the assembly of a bipolar spin- 
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cells  causes  nucleation  of abnormal 
microtubule arrays from tiny, unsep- 
arated  centrosomes.  Asynchronous 
interphase HeLa cells were injected 
with Plkl ÷, Plkl-, or Eg5 ÷ antibod- 
ies, fixed, and analyzed by immuno- 
fluorescence  microscopy.  (A) Confo- 
cal projection of the microtubules of 
mitotic cells  injected  with  Plkl-  or 
Plkl +. (B) Overlays of confocal pro- 
jections of microtubules (stained with 
anti--a-tubulin;  green)  and  cen- 
trosomes (stained  with CTR453; yel- 
low) in  mitotic  cells  injected  with 
either  Plkl +  or  Eg5 +.  (C)  Centro- 
somes,  stained  with  CTR453,  of 
uninjected  mitotic  cells  (Normal), 
Plkl+-injected  mitotic  cells (Plkl+), 
and  Eg5+-injec~ed  mitotic  cells 
(Eg5+). Bar, 10 I~m. 
die. Additional functions at later stages of mitosis are not 
excluded. We also found that Plkl+-induced inhibition of 
cell cycle progression is more pronounced in diploid, non- 
immortalized cells (Hs68) than in karyotypically abnormal 
carcinoma cells (HeLa). Thus, nonimmortalized cells may 
depend on Plkl  function and/or may monitor the proper 
maturation of centrosomes, before entering mitosis. This 
G2 checkpoint appears to be lost in at least some immor- 
talized cell lines. 
Plkl is Specifically Required for Entry into Mitosis 
We found that microinjection of anti-Plkl  antibodies re- 
sulted  in  a  significant  accumulation  of abnormal mitotic 
cells and in a severe block to cell division. Many injected 
cells displayed ball-like, condensed chromatin and mono- 
astral microtubule arrays reminiscent of interphase micro- 
tubules.  These  were  nucleated  from a  single  organizing 
center  that  contained  duplicated  but  small,  unseparated 
centrosOmes. At later times after injection of Plkl ÷ anti- 
bodies, we also observed an accumulation of multinucle- 
ated and micronucleated cells. These phenotypes may rep- 
resent  end  products  of  aborted  mitoses.  Alternatively, 
they might reflect additional requirements for Plkl  func- 
tion during later stages of cell division. Antibody injection 
had no effect on the kinetics of either entry into S phase or 
exit from S phase. Although negative results need to be in- 
terpreted  with  caution,  these  data  lend  no  support  to  a 
previous study attributing  to Plkl  an important  S  phase 
function (Hamanaka et al., 1994).  Considering our present 
data, together with the timing of cell cycle-dependent ex- 
pression and  activation of Plkl  (Lake and Jelinek,  1993; 
Golsteyn et al., 1994, 1995; Lee et al., 1995; Hamanaka et al., 
1995), it appears unlikely that Plkl should perform a ma- 
Lane and Nigg Mitotic Function of Human Polo-like Kinase 1  1709 Figure 6.  Injection of HeLa ceils with Plkl + inhibits the accumulation  of ~/-tubulin and MPM-2 reactivity characteristic  of mitotic cen- 
trosomes. Asynchronously  growing HeLa cells were injected with Plkl + or Eg5 + and analyzed by immunofluorescence  microscopy after 
20 h. (A) ~/-tubulin staining of uninjected  interphase and mitotic HeLa cells (left), and of Plkl +- and Eg5+-injected  mitotic HeLa cells 
(right). (B) Staining of the MPM-2 phospho-epitopes (MPM-2) and microtubules  (et-tubulin) of, from left to right, an uninjected  mitotic 
cell (Normal), a Plkl +-injected mitotic cell (Plkl+) and an Eg5+-injected mitotic cell (Eg5+). Bar, 10 p,m. 
jor function during S phase. This does not exclude, how- 
ever,  that  other  polo-like  kinases,  such  as  Snk  or  Fnk, 
might play important roles during G1, the G1/S transition, 
or S phase (Simmons et al., 1993; Donohue et al., 1995). 
Although  it is difficult to directly compare the  pheno- 
types produced  by Plkl ÷ antibody injection  to those  re- 
suiting from mutations of the putative Plkl homologues in 
Drosophila  and  yeasts (for references see  Introduction), 
our present data fall in line with some of the phenotypes 
observed for the polo  1 mutant of Drosophila and for plol ÷ 
gene disruptants in fission yeast. In contrast, cdc5 mutants 
of budding yeast arrest in late nuclear division with sepa- 
rated chromosomes and thus appear to retain the ability to 
construct a bipolar spindle. Considering the differences in 
the temporal and spatial choreography of mitotic events in 
the above organisms, it is not entirely unexpected that the 
inhibition of polo homologues may produce distinct phe- 
notypic consequences  in  different  species.  Also,  we  em- 
phasize that our data do not necessarily exclude additional 
functions  for mammalian  Plkl  at  later  stages  of mitotic 
progression. Both HeLa and Hs68 cells divided normally 
when  Plkl ÷  antibodies  were  injected  during  metaphase, 
but, considering the rapidity with which mitosis proceeds, 
it remains possible that antibodies injected during metaphase 
might not have reached their epitopes in time. Also, Plkl 
function may be redundant at later stages of mitosis. 
Plk  l  Is Required for the Functional Maturation of 
Centrosomes and Bipolar Spindle Formation 
The centrosomal and spindle abnormalities observed after 
Plkl ÷ injection strongly suggest a specific role for human 
Plkl  in the establishment of a  bipolar spindle. Normally, 
centrosomes increase  in  size shortly before the  onset  of 
mitosis, and concomitantly, they acquire the ability to nu- 
cleate highly dynamic spindle microtubules (Vorobjev and 
Nadehzdina,  1987;  Karsenti, 1991;  Kimble and Kuriyama, 
1992).  This  increase  in  size is  thought  to  reflect  a  func- 
tional maturation of centrosomes that can be visualized by 
monitoring  the  accumulation  of multiple  proteins  (Kalt 
and  Schliwa,  1993;  Kellogg et  al.,  1994;  Lange and  Gull, 
1995).  In HeLa cells, these include -y-tubulin (Zheng et al., 
1991;  Lajoie-Mazenc  et  al.,  1994)  and  MPM-2  reactive 
phosphoepitopes (Vandr6  et al.,  1986).  As shown by im- 
munofluorescent staining with several antibodies, the cen- 
trosomes in  Plkl+-injected  cells were much smaller than 
The Journal of Cell Biology,  Volume 135, 1996  1710 Table 111. Effect of  Anti-Plkl Antibodies on Cell Division in 
HeLa and Hs68 Cells Injected at Metaphase 
Antibody injected  Plkl  ÷  P/kl 
%  % 
HeLa 
Normally divided cells  88  (117/133)*  87  (106/122) 
Hs68 
Normally divided cells  91  (91/100)  97  (94/97) 
Widely scattered (one  cell per microscopic field) metaphase HeLa and Hs68 cells 
were microinjected with Plkl  ÷ and Plkl- IgG.  15 (HeLa) or 20 (Hs68) h after injec- 
tion, cells were fixed and analyzed by immunoflourescence microscopy.  Coverslips 
were scanned, and the percentage of injected cells that had divided calculated.  The to- 
tal results from two independent  experiments are shown. 
*  Number of normally divided cells/number of injected cells. 
Figure 7.  Plkl ÷ injection of Hs68 cells causes mitotic microtubule 
abnormalities,  and in the majority of cells, an interphase  arrest 
with duplicated  but small, unseparated  centrosomes.  Hs68 cells 
were injected with Plkl ÷ and incubated for 36 or 48 h. Then, cells 
were fixed and analyzed by immunofluorescence microscopy. (A) 
Confocal projection  of microtubules  (a-Tubulin)  and DNA of a 
Plkl+-injected  mitotic  cell after 36 h  incubation.  (B) CTR453 
staining of the centrosomes  of an uninjected  interphase  (Inter) 
and mitotic (Mitotic) Hs68 cell compared to a Plkl+-injected  in- 
terphase cell (Plkl +) after 48 h incubation. Bars, 10 ixm. 
normal mitotic spindle poles, and furthermore, contained 
reduced amounts of ~/-tubulin  and MPM-2 immunoreac- 
tivity, two markers for HeLa mitotic centrosomes. Attest- 
ing to the specificity of the observed effects, no changes in 
Table 11. Effect of  Anti-Plkl Antibodies on Cell Division in 
Human Diploid Fibroblasts (Hs68) 
Antibody injec~d  Plkl  +  Plkl - 
%  % 
36h 
Single interphase cells  72  (67/93)*  46.5  (64/138) 
Normally divided cells  §  4  (4/93)  52  (72/138) 
Mitotic cells*  16  (15/93)  1.5  (2/138) 
Micro-/Multinucleated cells  8  (7/93)  0  (9/138) 
Total  100  100 
48 h 
Single interphase cells  75  (67/89)  32  (37/116) 
Normally divided cells  ~  5  (4/89)  67  (78/116) 
Mitotic cells*  2  (2/89)  0  (0/116) 
Micro-/Multinucleated cells  18  (16/89)  1  ( 1  / 116) 
Total  100  100 
Asynchronously growing interphase Hs68 cells were microinjected with Plkl  ÷ or 
Plkl  IgG. At the times specified,  cells were fixed and analyzed by immunofluores- 
cence microscopy, The coverslip was scanned as in Table I, and scored for cells with 
the listed phenotypes.  The total results from four independent experiments are shown. 
* Mitotic cells injected with Plk  1  + display abnormal DNA condensation as described 
in the text (see also Fig. 7 A). 
*Total number of cells displaying  phenotype/total  number of injected cells. 
~Cells that have gone through at least one normal cell division. 
either centrosome size or marker acquisition were seen in 
monoastral microtubule arrays produced by the injection 
of antibodies against HsEg5, a human kinesin-related mo- 
tor protein (Blangy et al., 1995). These findings place Plkl 
upstream of HsEg5, and they imply that Plkl functions be- 
fore prometaphase, when HsEg5 (and its homologues) act 
to promote the migration of centrosomes (for review see 
Sawin and Endow, 1993; see also Heck et al., 1993; Blangy 
et al.,  1995).  Furthermore, they indicate that one of the 
early functions of Plkl concerns the recruitment of specific 
proteins to centrosomes. In line with this conclusion, it has 
previously  been  reported  that  the  centrosomal  antigen 
CP190  (formerly called  Bx63)  is  not  recruited  to  cen- 
trosomes  in  polo l  mutant  Drosophila  embryos  (Sunkel 
and Glover, 1988). 
During late G2/early prophase, the microtubule nucle- 
ation capacity of centrosomes increases drastically (Sny- 
der and Mclntosh, 1975; Kuriyama and Borisy, 1981, Kar- 
senti,  1991).  The  cell cycle regulation  of this  change  in 
centrosomal  activity remains  poorly understood,  but re- 
cent studies strongly implicate ~t-tubulin  as a  critical ele- 
ment in centrosomal microtubule nucleation (Joshi et al., 
1992; Frlix et al.,  1994; Stearns and Kirschner, 1994; Shu 
and Joshi, 1995; Sunkel et al.,  1995; Moritz et al. 1995a,b). 
Our finding that  anti-Plkl  antibodies inhibit the recruit- 
ment of 3,-tubulin to centrosomes raises the possibility that 
Plkl may participate in promoting the increased centroso- 
mal nucleation activity at the G2 to M transition. This no- 
tion is supported by the relatively low density of microtu- 
bules  in  the  monoasters  of Plkl÷-injected cells  (Fig.  5), 
and  the  apparent  absence  of centrosomal MPM-2 phos- 
phoepitope reactivity in these structures (Fig. 6 B). MPM-2 
reactive phosphoproteins have been found at mitotically 
activated microtubule organizing centers of all eukaryotic 
cell types examined (e.g., Vandr6 et al., 1984, 1986, 1991), 
and  dephosphorylation  of MPM-2  reactive  centrosomal 
components  directly  blocks  microtubule  nucleation  in 
vitro (Centonze and Borisy, 1990). 
Our data raise the possibility that Plkl may itself be an 
MPM-2  kinase.  Alternatively,  one  or  several  distinct 
MPM-2 kinase(s) may depend on Plkl for their activity. In 
direct support of the former interpretation, a putative Plkl 
homologue from Xenopus eggs was recently shown to be 
able  to  phosphorylate  the  Cdc25  phosphatase,  thereby 
generating  MPM-2  reactive sites  and  stimulating  Cdc25 
phosphatase activity (Kumagai and Dunphy, 1996).  Con- 
sidering  that  Cdc25C  phosphatase  is  a  key activator of 
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the interpretation of our results:  firstly, they bear directly 
on our finding that anti-Plkl  antibodies inhibit entry into 
mitosis  in nonimmortalized  Hs68  ceils  (see  below).  Sec- 
ondly, they raise the possibility that Plkl might in part reg- 
ulate centrosomal structure  and nucleation activity  through 
the  activation  of Cdc25  phosphatase,  and  consequently, 
Cdc2 kinase. In support of this view, there is compelling 
evidence that Cdc2 kinase plays an important role in the 
activation  of centrosomal microtubule nucleation  (Buen- 
dia et al., 1992; Verde et al., 1992), and both Cdc2 and B-type 
cyclins  accumulate  at  the  centrosome  during  interphase 
(Riabowol et al., 1989; Bailly et al., 1989, 1992; Pines and 
Hunter, 1991; Gallant and Nigg, 1992). 
The molecular identity of all MPM-2  antigens has not 
yet been established, but it is intriguing that, in addition to 
Cdc25, several  other mitotic regulators  are MPM-2  anti- 
gens. These include Wee1, Mytl, Cdc27, and NIMA (Kuang 
et al., 1994;  King et al., 1995;  Mueller et al., 1995a,b; Ye 
et al., 1995).  It will clearly be interesting to search for addi- 
tional Plkl substrates amongst these proteins. In particu- 
lar, it seems plausible that Plkl  might phosphorylate  the 
Weel and/or Mytl kinases, thereby down-regulating Cdc2- 
inhibitory pathways. Likewise, it is attractive to speculate 
that  Plk's  might  phosphorylate  the  Cdc27  gene  product 
and perhaps other components of the anaphase promoting 
complex  (Irniger et al.,  1995;  King  et al.,  1995;  Tugend- 
reich et al., 1995), and thereby contribute to the regulation 
of anaphase onset. 
A Checkpoint Monitoring Centrosome Maturation ? 
In an elegant study, microsurgical removal of centrosomes 
from cultured mammalian cells was shown to prevent all 
aspects of mitosis, including the activation of Cdc2 kinase 
(Maniotis  and  Schliwa,  1991).  This  observation  strongly 
suggested  a  link between  centrosomes  and  Cdc2  activa- 
tion, but the nature of this  link remained  unknown (for 
discussion see  Bailly and  Bornens,  1992).  A  priori, cen- 
trosomes might exert control over Cdc2 via a positive sig- 
nal (emitted by mature centrosomes), via a negative signal 
(emitted by immature centrosomes), or both. The data by 
Maniotis  and Schliwa (1991)  argue in favor of a positive 
signal, but do not exclude the existence of inhibitory sig- 
nals. A  rote of Plkl in stimulating the Cdc25 phosphatase 
has  recently  been  established  (Kumagai  and  Dunphy, 
1996), and a possible role for this kinase in counteracting 
inhibitory pathways involving Wee1 and/or Mytl kinase is 
worth  investigating.  Most  intriguingly,  we  have  shown 
here that  nonimmortalized  diploid fibroblasts  (Hs68)  re- 
spond to the inhibition of Plkl function by a G2 arrest.  In 
contrast,  karyotypicalIy  abormal cells (HeLa)  attempt  to 
proceed through mitosis despite the loss of Plkl function, 
indicating that they do not depend on Plkl for the activa- 
tion of Cdc2. Such a scenario appears plausible, since tu- 
mor cells frequently display deregulated expression of cell 
cycle regulators, including Cdc25 (Hunter and Pines, 1994; 
Galaktionov  et at.,  1995).  Thus, we propose that normal 
cells may exhibit a checkpoint that causes a G2 arrest in 
response to the lack of Plkl function and/or the resulting 
lack of functionally mature mitotic centrosomes. This cen- 
trosome  maturation-related  checkpoint  would appear to 
be  absent  from  HeLa  cells.  Loss  of such  a  checkpoint 
might be common among tumor ceils and conceivably con- 
tribute to the development of aneuploidies (Murray, 1992; 
Hartwell and Kastan, 1994). 
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